Literature DB >> 20396549

2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals.

Hai-Rim Shin1, Kyu-Won Jung, Young-Joo Won, Jae-Gahb Park.   

Abstract

PURPOSE: To estimate the number of cancer cases during 2002 in Korea through a nationwide hospital based cancer registration by the Korea Central Cancer Registry (KCCR).
MATERIALS AND METHODS: One hundred and thirty nine hospitals participated in the KCCR program in 2002. Cancer cases were coded and classified according to the International Classification of Diseases for Oncology 2(nd) edition (ICD-O-2). The software program "IARC Check" was used to evaluate the quality of registered cancer cases. Of the 122,770 malignancies registered, 11,732 (9.6%) duplicated malignancies were excluded. Among the remaining 102,677 malignancies, 3,652 (3.6%) cases with carcinoma in situ (Morphology code/2) were separated. Finally, 99,025 malignancies were analyzed.
RESULTS: Of the total of 99,025 malignancies, 55,398 (55.9%) cases were males and 43,627 (44.1%) were females. More than one third of cases were from the elderly (65 years old and more). The six leading primary cancer sites in the order of their relative frequency, were stomach (24.0%), followed by the lung (16.0%), the liver (15.4%), the colorectum (11.6%), the bladder (3.2%), and the prostate (3.0%) among males. In females, the breast (16.8%) was the common cancer site, followed by the stomach (15.3%), the colorectum (10.7%), the thyroid gland (9.5%), the cervix uteri (9.1%), and the lung (6.6%).
CONCLUSION: With the continued increase in cancer cases especially prostate cancer among males and thyroid cancer among females, the total number of registered cancer cases in Korea continues to rapidly increase.

Entities:  

Keywords:  Annual report; Cancer registry

Year:  2004        PMID: 20396549      PMCID: PMC2855096          DOI: 10.4143/crt.2004.36.2.103

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  63 in total

1.  Programmed cell death 6 (PDCD6) as a prognostic marker for gastric cancers.

Authors:  Jung Hwan Yoon; Yoo Jin Choi; Sung Geun Kim; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Tumour Biol       Date:  2011-12-13

2.  Prognostic significance of MRI-detected bladder muscle and/or serosal invasion in patients with cervical cancer treated with radiotherapy.

Authors:  H Nam; S J Huh; W Park; D S Bae; B G Kim; J H Lee; C K Kim; B K Park
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

3.  Behcet's disease associated with malignancy in Korea: a single center experience.

Authors:  Joong Kyong Ahn; Ji Min Oh; Jaejoon Lee; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Rheumatol Int       Date:  2009-12-17       Impact factor: 2.631

4.  Characteristics of synchronous cancers in gastric cancer patients.

Authors:  Ja Seong Bae; Jun Ho Lee; Keun Won Ryu; Young Woo Kim; Jae Moon Bae
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

5.  Chemotherapy for advanced gastric cancer: slow but further progress.

Authors:  Yeul Hong Kim
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

6.  Efficacy and safety study of docetaxel as salvage chemotherapy in metastatic gastric cancer failing fluoropyrimidine and platinum combination chemotherapy.

Authors:  Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Tae-Won Kim; Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim; Jung Shin Lee; Yoon-Koo Kang
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

7.  Gene promoter hypermethylation in tumors and plasma of breast cancer patients.

Authors:  Young Kyung Bae; Young Ran Shim; Joon Hyuk Choi; Mi Jin Kim; Edward Gabrielson; Soo Jung Lee; Tae Yoon Hwang; Sei One Shin
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

8.  A multi-center, phase ii clinical trial of Padexol (paclitaxel) and cisplatin for patients suffering with advanced gastric cancer.

Authors:  Min Kyoung Kim; Kyung Hee Lee; Myung Soo Hyun; Young Rok Do; Hong Suk Song; Won Sik Lee; Keon Uk Park; Jin Ho Baek; Jong Gwang Kim
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

9.  Thymidylate synthase, thymidine phosphorylase, VEGF and p53 protein expression in primary colorectal cancer for predicting response to 5-fluorouracil-based chemotherapy.

Authors:  Myung-Ju Ahn; Jung-Hye Choi; Ho-Suk Oh; Young-Yeul Lee; In-Soon Kim; Il-Young Choi; Kang-Hong Lee; Kang-Won Song; Chan-Kum Park
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

10.  Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm.

Authors:  Rack Cheon Bae; Seong Woo Jeon; Han Jin Cho; Min Kyu Jung; Young Oh Kweon; Sung Kook Kim
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.